
Part 1: Complexities in Data Collection Blog Post
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara highlights challenges with data volume and complexity.
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara highlights challenges with data volume and complexity.
がんと自己免疫を結合「有効性または安全性の観点から自己免疫疾患での最適な選択肢に、腫瘍学における投与計画が直接有用な情報を提供することはないかもしれません。」The level of immune activation…
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic heritage, but in history and folklore. In Chinese literature from the 16th century, Journey to the…
In this podcast, Dr. Chris Bouton, Senior VP and Head of AI at Certara, highlights how generative AI is being applied to increase the efficiency of drug discovery and development….
The article titled “Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women,” authored by Jia Ning, Amita Pansari,…
Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with our free, downloadable Define-XML format guide.
弊社のCDISC標準管理のための完全ガイドによって、CDISCデータ標準に対する管理とバリデーションを簡略化する方法を知りましょう。
RADNOR, PA – 2024年10月30日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced the appointment of Dr. Tong Zhu, FCP, to lead its…
要旨:T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy. Glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) is expressed on immune cells including regulatory…